Subject    :    [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
Writer KDA
Date 2017-07-06 11:02:30 Hit 7,105
Diabetes Metab J. 2017 Apr;41(2):135-145. English.
Published online Jan 11, 2017.  https://doi.org/10.4093/dmj.2017.41.2.135 
Copyright © 2017 Korean Diabetes Association
   
Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
Kyung-Wan Min,1 Bon Jeong Ku,2 Ji-Hyun Lee,3 Min-Seon Kim,4 Kyu-Jeung Ahn,5 Moon-Kyu Lee,6 Satoshi Kokubo,7 Satoshi Yoshida,7 Hyun-Ji Cho,8 and Bong-Soo Cha9
1Department of Internal Medicine, Eulji General Hospital, Eulji University School of Medicine, Seoul, Korea.
2Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.
3Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.
4Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.
5Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University Medical Center, Seoul, Korea.
6Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
7Astellas Pharma Inc., Tokyo, Japan.
8Astellas Korea Inc., Seoul, Korea.
9Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Corresponding author: Bong-Soo Cha. Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Email: bscha@yuhs.ac 
 
Received August 01, 2016; Accepted October 25, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

 
Abstract

Background

This is a subgroup analysis of Korean patients from a phase 3 clinical trial investigating the efficacy and safety of ipragliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin.

Methods

This multicenter, placebo-controlled, double-blind, parallel-group study was carried out between November 2011 and January 2013. Patients entered a 2-week placebo pretreatment period, followed by a 24-week treatment period with either ipragliflozin (50 mg/day) or placebo, while continuing metformin. Efficacy outcomes (glycosylated hemoglobin [HbA1c], fasting plasma glucose [FPG], and body weight) and safety outcomes (treatment-emergent adverse events [TEAEs]) were measured and compared between the two treatment groups for patients enrolled in all 18 study sites in Korea.

Results

Eighty-two Korean patients received ipragliflozin (n=43) or placebo (n=39) during the study period. Mean changes in HbA1c levels from baseline to the end of treatment were –0.97% in the ipragliflozin group and –0.31% in the placebo group, with an adjusted between-group difference of –0.60% (P P

Conclusion

Ipragliflozin treatment in addition to metformin led to significant improvement in glycemic outcomes and reduction in body weight in Korean patients with type 2 diabetes mellitus, compared with metformin treatment alone; the safety profile was comparable in both groups.

   
Keywords:
Asia; Diabetes mellitus, type 2; Ipragliflozin; Korea; Metformin; Randomized controlled trial; Sodium-glucose cotransporter 2 inhibitor

Articles - Reviews in DMJ
No. Subject Date Hit ↓
Notice : [2017 Oct;41(5)] Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD [2017 Oct;41(5)] Generation of Insulin-Expressing Cells in Mouse Sma... 2018-12-03 73
Notice : [2017 Oct;41(5)] Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data [2017 Oct;41(5)] Features of Long-Standing Korean Type 2 Diabetes Me... 2018-12-03 82
Notice : [2017 Oct;41(5)] Performance of the Achutha Menon Centre Diabetes Risk Score in Identifying Prevalent Diabetes in Tamil Nadu, India [2017 Oct;41(5)] Performance of the Achutha Menon Centre Diabetes Ri... 2018-12-03 78
Notice : [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione... 2018-12-03 83
Notice : [2017 Oct;41(5)] Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017 [2017 Oct;41(5)] Insulin Therapy for Adult Patients with Type 2 Diab... 2018-12-03 75
Notice : [2017 Oct;41(5)] Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus [2017 Oct;41(5)] Combination Therapy of Oral Hypoglycemic Agents in ... 2018-12-03 80
Notice : [2017 Oct;41(5)] Monotherapy in Patients with Type 2 Diabetes Mellitus [2017 Oct;41(5)] Monotherapy in Patients with Type 2 Diabetes Mellit... 2018-12-03 78
Notice : [2017 Oct;41(5)] Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association [2017 Oct;41(5)] Antihyperglycemic Agent Therapy for Adult Patients ... 2018-12-03 82
Notice : [2017 Oct;41(5)] Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy Metabolism [2017 Oct;41(5)] Skeletal Muscle Thermogenesis and Its Role in Whole... 2018-12-03 77
Notice : [2017 Aug;41(4)] Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4 [2017 Aug;41(4)] Factors Associated with Improved Glycemic Control b... 2018-12-03 71
Notice : [2017 Aug;41(4)] In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells [2017 Aug;41(4)] In Vitro Effect of Fatty Acids Identified in the P... 2018-12-03 80
Notice : [2017 Aug;41(4)] Depression and Mortality in People with Type 2 Diabetes Mellitus, 2003 to 2013: A Nationwide Population-Based Cohort Study [2017 Aug;41(4)] Depression and Mortality in People with Type 2 Diab... 2018-12-03 77
Notice : [2017 Aug;41(4)] Determinants of Long-Term Durable Glycemic Control in New-Onset Type 2 Diabetes Mellitus [2017 Aug;41(4)] Determinants of Long-Term Durable Glycemic Control ... 2018-12-03 79
Notice : [2017 Aug;41(4)] Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea [2017 Aug;41(4)] Effects of High-Dose α-Lipoic Acid on Heart Rate ... 2018-12-03 77
Notice : [2017 Aug;41(4)] Comparison of Glucose Area Under the Curve Measured Using Minimally Invasive Interstitial Fluid Extraction Technology with Continuous Glucose Monitoring System in Diabetic Patients [2017 Aug;41(4)] Comparison of Glucose Area Under the Curve Measured... 2018-12-03 79
Notice : [2017 Aug;41(4)] The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis [2017 Aug;41(4)] The Effectiveness of Green Tea or Green Tea Extract... 2018-12-03 72
Notice : [2017 Aug;41(4)] Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs [2017 Aug;41(4)] Unusual Suspects in the Development of Obesity-Indu... 2018-12-03 80
197 [2017 Jun;41(3)] Satisfaction Survey on Information Technology-Based... 2017-07-06 7,536
196 [2017 Jun;41(3)] The Effect of 12 Weeks Aerobic, Resistance, and Com... 2017-07-06 7,479
195 [2017 Jun;41(3)] Impact of Gender on the Association between Low Ser... 2017-07-06 7,428
194 [2017 Jun;41(3)] Physician-Directed Diabetes Education without a Med... 2017-07-06 7,089
193 [2017 Jun;41(3)] Knowledge, Attitude, and Practice of Iranian Intern... 2017-07-06 7,063
192 [2017 Jun;41(3)] Comparison of Antidiabetic Regimens in Patients wit... 2017-07-06 7,253
191 [2017 Jun;41(3)] Diabetes Prevention in Australia: 10 Years Results ... 2017-07-06 7,054
190 [2017 Jun;41(3)] Comprehensive Approach for Managing the Older Perso... 2017-07-06 6,761
189 [2017 Apr;41(2)] A Cutoff for Age at Menarche Predicting Metabolic S... 2017-07-06 6,737
188 [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in... 2017-07-06 7,105

목록

Gets the previous 5 pages.   Go to previous page.  [1]   2   3   4   5     Go to next page. Gets the next  5 pages.